Prefer Newsweek on Google to see more of our trusted coverage when you search. It's time for the penultimate episode of "Paradise" Season 2. Episode 7, "The Final Countdown," airs Monday, March 23, ...

Navia Benefit Solutions, Inc. (Navia) is informing nearly 2.7 million individuals of a data breach that exposed their sensitive information to attackers. An investigation into the incident revealed ...

Newcastle’s UEFA Champions League run came to a screeching halt on Wednesday, but not until after they traded haymakers (and goals) with the mighty Barcelona in a breathless first half, before ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

The Black Ops 7 Season 2 Reloaded release time is nigh. This mid-season update brings new multiplayer maps, modes, and events, as well as a new Zombies map and tons of new weapons. On top of that, it ...

If there’s one thing Fallout has managed to do, it’s pique our curiosity with the many questions it raises. Even when it yields answers, we end up with far more questions, which just draws us further ...

It's going to be a soggy next couple of days a front slowly moves through and stalls across the area.Heavy rain continues to fall this morning. A Flood Advisor CBP warns: 'Not the way' after officers ...

Apple released iOS 26.2 on Friday, Dec. 12 and, alongside it, iOS 18.7.3. However, reports emerged that while it was installing nicely on iPhones that couldn’t run iOS 26, nobody else was getting it.

Inflation in November fell to 2.7%, the Bureau of Labor Statistics said Thursday, a positive sign for consumers on its face. Subscribe to read this story ad-free Get unlimited access to ad-free ...

Data collection issues skewed the latest Consumer Price Index report, economists warned, clouding the picture for the Federal Reserve as it also grapples with a cooling labor market. By Colby Smith ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...